These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 20716963)
1. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963 [TBL] [Abstract][Full Text] [Related]
2. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. Jordan C; Li HH; Kwan HC; Francke U BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Wu H; Tao J; Chen PJ; Shahab A; Ge W; Hart RP; Ruan X; Ruan Y; Sun YE Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18161-6. PubMed ID: 20921386 [TBL] [Abstract][Full Text] [Related]
4. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome. Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. Petazzi P; Sandoval J; Szczesna K; Jorge OC; Roa L; Sayols S; Gomez A; Huertas D; Esteller M RNA Biol; 2013 Jul; 10(7):1197-203. PubMed ID: 23611944 [TBL] [Abstract][Full Text] [Related]
6. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling. Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102 [TBL] [Abstract][Full Text] [Related]
7. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995 [TBL] [Abstract][Full Text] [Related]
8. Mecp2-null mice provide new neuronal targets for Rett syndrome. Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361 [TBL] [Abstract][Full Text] [Related]
9. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes. Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767 [TBL] [Abstract][Full Text] [Related]
11. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. Koelsch KA; Webb R; Jeffries M; Dozmorov MG; Frank MB; Guthridge JM; James JA; Wren JD; Sawalha AH J Autoimmun; 2013 Mar; 41():168-74. PubMed ID: 23428850 [TBL] [Abstract][Full Text] [Related]
12. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Peddada S; Yasui DH; LaSalle JM Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435 [TBL] [Abstract][Full Text] [Related]
14. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway. Roux JC; Zala D; Panayotis N; Borges-Correia A; Saudou F; Villard L Neurobiol Dis; 2012 Feb; 45(2):786-95. PubMed ID: 22127389 [TBL] [Abstract][Full Text] [Related]
15. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome. Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934 [TBL] [Abstract][Full Text] [Related]
16. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome. Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Samaco RC; Hogart A; LaSalle JM Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769 [TBL] [Abstract][Full Text] [Related]
18. Histone H3 and H4 modification profiles in a Rett syndrome mouse model. Urdinguio RG; Pino I; Ropero S; Fraga MF; Esteller M Epigenetics; 2007; 2(1):11-4. PubMed ID: 17965622 [TBL] [Abstract][Full Text] [Related]
19. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980 [TBL] [Abstract][Full Text] [Related]
20. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]